tadalafil has been researched along with 1-(4-(4-hydroxyphenyl)piperazin-1-yl)ethanone in 1 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (1-(4-(4-hydroxyphenyl)piperazin-1-yl)ethanone) | Trials (1-(4-(4-hydroxyphenyl)piperazin-1-yl)ethanone) | Recent Studies (post-2010) (1-(4-(4-hydroxyphenyl)piperazin-1-yl)ethanone) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 12 | 0 | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bischoff-Kont, I; Chaikuad, A; Faudone, G; Fürst, R; Heering, J; Kaiser, A; Knapp, S; Merk, D; Rachor, L; Willems, S; Zhubi, R | 1 |
1 other study(ies) available for tadalafil and 1-(4-(4-hydroxyphenyl)piperazin-1-yl)ethanone
| Article | Year |
|---|---|
Propranolol Activates the Orphan Nuclear Receptor TLX to Counteract Proliferation and Migration of Glioblastoma Cells.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Glioblastoma; HEK293 Cells; Humans; Molecular Structure; Orphan Nuclear Receptors; Propranolol; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship | 2021 |